Association of oral bisphosphonates with cardioembolic ischemic stroke: a nested case-control study
Conclusion: The use of oral bisphosphonates increases specifically the odds of cardioembolic IS, in a duration-dependent manner, while leaves materially unaffected the odds of non-cardioembolic IS.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Atrial Fibrillation | Calcium | Cardiology | Databases & Libraries | Drugs & Pharmacology | Epidemiology | Heart | Ischemic Stroke | Spain Health | Stroke | Study